NovaMed (NOVA) Reports Q1 Miss
Tweet
Share
E-mailGet Alerts NOVA Hot Sheet
Join SI Premium – FREE
NovaMed (NASDAQ: NOVA) reported Q1 EPS of $0.12, $0.07 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $29.7 million versus the consensus estimate of $38.24 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
- Commercial Metals (CMC) Tops Q3 EPS by 3c, Beats on Revenue
- McCormick & Co. (MKC) Tops Q2 EPS by 10c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
